Ultrasound scoring systems: assessing disease activity in rheumatoid arthritis
Authors:
J. Hurňáková; J. Gatterová; K. Pavelka
Authors place of work:
Revmatologický ústav, Praha
Published in the journal:
Čes. Revmatol., 20, 2012, No. 2, p. 62-72.
Category:
Overview Reports
Summary
Musculoskeletal ultrasound (US) is a modern imaging modality, increasingly gaining popularity among rheumatologists for its considerable diagnostic potential. Development of high-frequency transducers required for visualization of superficially lying structures, in contrast to radiography, has allowed an examination of soft tissues, e.g. tendons and synovial hypertrophy, much more precisely. Ultrasonographic examination of joints facilitates diagnosing rheumatoid arthritis, particularly at an early stage, when clinical assessment is often negative or at least non-specific, at best in a short so-called ”window of opportunity.” Its benefit is not only in the initial diagnosis. US also plays an important role in accurate assessment of disease activity whenever needed. In this way, US aids clinicians to make further treatment decisions, especially in the new era of highly effective biologic agents. Many previous studies have shown, that sonography is more sensitive in monitoring a disease activity than presently most used composite indices (DAS, DAS28, SDAI, CDAI indices). However, there is a need for a standardized measurement system for investigating, detecting and scoring of pathological findings on a global level. This present study informs about ultrasound scoring systems mostly used in disease activity assessment and gives an overview of summarized scoring Indices.
Key words:
rheumatoid arthritis, synovitis, ultrasonography, ultrasound scoring systems, disease activity assessment, remission
Zdroje
1. Conaghan PG, OęConnor P, Mc Gonable D, et al. Elucidation of the relationship between synovitis and bone damage: a randomized magnetic resonance imaging study of individual joints in patients with early rheumatid arthritis. Arthritis Rheum 2003;48:64-71.
2. Pap T, Distler O. Linking angiogenesis to bone destruction in arthritis. Arthritis Rheum 2005;52:1346-1348.
3. Fitz Gerald O, Bresnihan B. Synovial membrane cellularity and vascularity. Ann Rheum Dis 1995;54:511-515.
4. Koch AE. Angiogenesis: implications for rheumatoid arthritis. Arthritis Rheum 1998;41:951-962.
5. Naredo E, Collado P, Cruz A, et al. Longitudinal power Doppler ultrasonographic assessment of joint inflammatory activity in early rheumatoid arthritis: predictive value in disease activity and radiologic progression. Arthritis Rheum 2007;57:116–124.
6. Wakefield RJ, Green MJ, Marzo-Ortega H, et al. Should oligoarthritis be reclassified? Ultrasound reveals a high prevalence of subclinical disease. Ann Rheum Dis 2004; 63:382-385.
7. Freeston JE, Wakefield RJ, Conaghan PG, et al. A diagnostic algorithm for persistence of very early inflammatory arthritis: the utility of power doppler ultrasound when addend to conventional assessment tools Ann Rheum Dis 2010;69:417-419.
8. Nell VP, Machold KP, Eberl G, et al. Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patiens with early rheumatoid arthritis. Rheumatology (Oxford) 2004;43:906-914.
9. Lard LR, Visser H, Speyer I, et al. Early versus delayed treatment in patiens with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies. Am J Med 2001;6:498-500.
10. Kane D, Balint PV. Ultrasonography is superior to clinical examination in the detection and localization of knee joint effusion in rheumatoid arthritis. J Rheumatol 2003;30:908-909.
11. Karim Z, Wakefield RJ, Quinn M Validation and reproducibility of ultrasonography in the detection of synovitis in the knee: a comparison with arthroscopy and clinical examination. Arthirits Rheum 2004;50:387-394.
12. Szkudlarek M, Klarlund M, Narvestad E, et al. Ultrasonography of metatarsophalangeal joints in rheumatoid arthritis: comparison with magnetic resonance imaging, conventional radiography, and clinical examination. Arthritis Rheum 2006;2:R52.
13. Naredo E, Bonilla G, Gamero F, et al. Assessment of inflammatory activity in rheumatid arthritis: a comparative study of clinical evaluation with grey scale and power Doppler ultrasonography. Ann Rheum Dis 2005;64:375-381.
14. Backhaus M, Kamradt T, Sandrock D, et al. Arthritis of the finger joints: a comprehensive approach comparing conventional radiography, scintigraphy, ultrasound and contrast-enhanced magnetic resonance imaging. Arthritis Rheum 1999;42:1232-1245.
15. Matsos M, Harish S, Zia P, et al. Ultrasound of the hands and feet for rheumatological disorders: influence on clinical diagnostic confidence and patient management. Skeletal Radiol 2009;38:1049-1054.
16. Brown AK, Conaghan PG, Karim Z, et al. An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum 2008;58:2958-2967.
17. Balsa A, de Miguel E, Castillo C. Superiority of SDAI over DAS-28 in assessment of remission in rheumatoid arthritis patiens using power Doppler ultrasonography as a gold standard. Rheumatology (Oxf) 2010;49:683-690.
18. Smolen JS, Aletaha D. Monitoring rheumatoid arthritis. Curr Opin Rheumatol 2011;23:252-258.
19. Brown AK, Quinn MA, Karim Z, et al. Presence of significant synovitis in rheumatoid arthritis patiens with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression. Arthritis Rheum 2006;54:3761-3773.
20. Saleem B, Brown AK, Keen H, et al. Should imaging be a component of rheumatoid arthritis remission criteria? A comparison between traditional and modified composite remission scores and imaging assessments. Ann Rheum Dis 2011;70:792-798.
21. Aletaha D, Ward MM, Machold KP, Nell VP, Stamm T, Smolen JS. Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states. Arthritis Rheum 2005;52:2625-36.
22. Wakefield RJ. Freeston JE, Hensor EMA, et al. Delay in Imaging Versus Clinical Response: A rationale for Prolonged Treatment with anti-tumor necrosis factor medication in early rheumatoid arthritis. Arthritis Rheum 2007;57:1564-1567.
23. Iagnocco A, Perella C, Naredo E, et al. Etanercept in the treatment of rheumatoid arthritis: clinical follow-up over one year by ultrasonography. Clin Rheumatol 2008;27: 491-496.
24. Ribbens C, Andre B, Marcelis S, et al. Rheumatoid hand joint synovitid: gray-scale and power Doppler US quantifications following anti-tumor necrosis factor-alpha treatment: pilot study. Radiology 2003;2:562-569.
25. Terslev L, Torp-Pedersen S, Qvistagard E, et al. Effects of treatment with etanercept (Enbrel, TNRF:Fc) on rheumatoid arthritis evaluated by Doppler ultrasonography. Ann Rheum Dis 2003,62:178-181.
26. Taylor PC, Steuer A, Gruber J, et al. Ultrasonographic and radiographic results from a two-year controlled trial of immediate or one-year-delayed addition of infliximab to ongoing methotrexate therapy in patiens with erosive early rheumatoid arthritis. Arthritis Rheum 2006;54:47-53.
27. Naredo E, Moller J, Cruz A, et al. Power Doppler ultrasonographic monitoring of response to anti-tumor necrosis factor therapy in patiens with rheumatoid arthritis. Arthritis Rheum 2008,58:2248-2256.
28. Filippucci E. Power Doppler sonography monitoring of synovial perfusion at wrist joint in rheumatoid patiens treated with adalimumab. Ann Rheum Dis 2006,65:1433-1437.
29. Iagnocco A. Clinical and ultrasonographic monitoring of response to adalimumab treatment in rheumatoid arthritis. J Rheumatol 2008,35:35-40.
30. Fiocco U, Ferro F, Vezzu M, et al. Rheumatoid and psoriatic knee synovitid: clinical, grey scale, and power Doppler ultrasound assessment of the response to etanercept. Ann Rheum Dis 2005;64: 899-905.
31. Wakefield RJ, Freeston JE, Hensor EM, et al. Delay in imaging versus clinical response: a rationale for prolonged treatment with anti-tumor necrosis factor medication in early rheumatoid arthritis. Arthritis Rheum 2007;57:1564–1567.
32. Ellegaard K, Christensen R, Torp-Pedersen S, et al. Ultrasound Doppler measurements predict success of treatment with anti-TNF-alpha drug in patiens with rheumatoid arthritis: a prospective kohort study. Rheumatology 2011;50:506-512.
33. Iagnocco A. Imaging the joint in osteoarthritis: a place for ultrasound? Best Pract Res Clin Rheumatol 2010;24: 27-38.
34. Grassi W, Salaffi P, Filippucci E. Ultrasound in rheumatology Best Pract Res Clin Rheumatol 2005;19:467-485.
35. Naredo E, Bijlsma JW. Becoming a musculoskeletal ultrasonographer. Best Pract Res Clin Rheumatol 2009;23: 257-267.
36. Naredo E, Wakefield RJ, Iagnocco A, et al. The OMERACT Ultrasound Task Force – Status and Prospectives. J Rheumatol 2011;38:2063-2067.
37. Mandl P, Naredo E, Wakefield RJ, et al. A systematic literature review analysis of ultrasound joint count and scoring systems to assess synovitis in rheumatoid arthritis according to the OMERACT filter. J Rheumatol 2011;38: 2055-2062.
38. Wakefield RJ, Balint PV, Szkudlarek M, et al. Musculoskeletal ultrasound including definitions for ultrasonographic pathology. J Rheumatol 2005;32:2485-2487.
39. Gatterová J, Seidl Z, Vaněčková M, et al. Skórovací systémy při hodnocení progrese revmatoidní artritidy. Čes Revmatol 2008;16:89-91.
40. Hameed B, Pilcher J, Heron C, et al. The relation between composite ultrasound measures and the DAS28 score, its components and acute phase markers in adult RA. Rheumatology 2008;47:476–80.
41. Fukae J, Shimizu M, Kon Y, Tanimura K, et al. Screening for rheumatoid arthritis with finger joint power Doppler ultrasonography: quantification of conventional power Doppler ultrasonographic scoring. Mod Rheumatol 2009;19:502-506.
42. Scheel AK, Hermann KG, Kahler E, et al. A novel ultrasonographic synovitis scoring system suitable for analyzing finger joint inflammation in rheumatoid arthritis. Arthritis Rheum 2005;52:733-43.
43. Ostergaard M, Ejbjerg B, Szkudlarek M. Imaging in early rheumatoid arthritis: roles of magnetic resonance imaging, ultrasonography, conventional radiography and computed tomography. Best Pract Res Clin Rheumatol 2005;19:91–116.
44. Spencer SP, Ganeshalingam S, Kelly S, Ahmad M. The role of ultrasound in the diagnosis and follow-up of early inflammatory arthritis. Clinical Radiology 2012;67:15-23.
45. Gatterová J. Přínos ultrazvuku pro diagnostiku časných forem revmatických onemocnění. Postgraduální medicína 2011;13:523-525.
46. Wakefield RJ, Brown AK, O’Connor PJ, et al. Power Doppler sonography: improving disease activity assessment in inflammatory musculoskeletal disease. Arthritis Rheum 2003;48:285–288.
47. Schmidt W.A, Backhaus M. What the practising rheumatologist needs to know about the technical fundamentals of ultrasonography. Best Pract Res Clin Rheumatol 2008; 22:981-999.
48. Mann H. Využití sonografie při diagnostice a léčbě revmatoidní artritidy. Čes Revmatol 2010;18:120-124.
49. Schmidt WA. Doppler sonography in rheumatology. Best Pract Res Clin Rheumatol 2004;18:827-846.
50. Qvistgaard E, Rogind H, Torp-Pederson S, et al. Quantitative ultrasonography in rheumatoid arthritis: evaluation of inflammation by Doppler technique. Ann Rheum Dis 2001;60:690–3.
51. Walther M, Harms H, Krenn V, et al. Correlation of power Doppler sonography with vascularity of the synovial tissue of the knee joint in patients with vascularity of the synovial tissue of the knee joint in patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 2001;44:331-338.
52. Szkudlarek M, Court-Payen M, Jacobsen S, et al. Interobserver agreement in ultrasonography of the Finger and toe joint inflammation in rheumatoid arthritis. Arthritis Rheum 2003;48:955-962.
53. Taylor PC, Steuer A, Gruber J, et al. Comparison of ultrasonographic assessment of synovitis and joint vascularity with radiographic evaluation in a randomized, placebo-controlled study of infliximab therapy in early rheumatoid arthritis. Arthritis Rheum 2004;50:1107-1116.
54. Naredo E, Gamero F, Bonilla G, et al. Ultrasonographic assessment of inflammatory activity in rheumatoid arthritis: comparison of extended versus reduced joint evaluation. Clin Exp Rheumatol 2005;23:881–884.
55. Ozgocmen S, Ozdemir H, Kiris A, et al. Clinical evaluation and Power Doppler sonography in rheumatoid arthritis: evidence for ongoing synovial inflammation in clinical remission. South Med J 2008;101:240-245.
56. Sciré CA, Montecucco C, Codullo V, et al. Ultrasonographic evaluation of joint involvement in early rheumatoid arthitis in clinical remission: power Doppler signal predicts short-term relace. Rheumatology 2009;48:1092-1097.
57. Dougados M, Jousse-Joulin S, Mistretta F. Evaluation of several ultrasonography scoring systems for synovitis and comparison to clinical examination: Results from a prospective multi-center study of rheumatoid arthritis. Ann Rheum Dis 2010;69:828-833.
58. Smolen JS, Breedveld FC, Schiff MH, Kalden JR, Emery P, Eberl G, et al. S Simplified Disease Activity Index for rheumatoid arthritis for use in clinical practise. Rheumatology (Oxford) 2003;42:244-257.
59. Aletaha D, Stamm T, Smolen JS. Validation od the Simplified Disease Activity Index (SDAI) in an observational cohort of patients with rheumatoid arthritis. Ann Rheum Dis 2004;63Suppl1:S111.
60. Naredo E, Rodríguez M, Campos C, et al. Validity, reproducibility, and responsiveness of a twelve-joint simplified power Doppler ultrasonographic assessment of joint inflammation in rheumatoid arthritis. Arthritis Rheum 2008;59:515-522.
61. Backhaus M, Ohrndorf S, Kellner H, et al. Evaluation of a novel 7-joint ultrasound score in daily rheumatologic practice: A pilot project. Arthritis Rheum 2009;61:1194-1201.
62. Hammer HB, Sveinsson M, Kongtorp AK, et al. A 78-joints ultrasonographic assessment is associated with clinical assessments and is highly resposnive to improvement in a longitudinal study of patiens with rheumatoid arthritis starting adalimumab treatment. Ann Rheum Dis 2010;69:1349-1351.
63. Hammer HB, Kvien TK. Comparison of 7- to 78-joint ultrasonography scores: all different joint combinations show equal response to adalimumab treatment in patiens with rheumatoid arthritis. Arthritis Research & Therapy 2011,13:R78.
Štítky
Dermatology & STDs Paediatric rheumatology RheumatologyČlánok vyšiel v časopise
Czech Rheumatology
2012 Číslo 2
Najčítanejšie v tomto čísle
- Raynaud’s phenomenon and peripheral ischemic syndromes
- Recommendations of the Czech Society for Rheumatology for the treatment of gouty arthritis
- Obesity, adipose tissue and cardiovascular risk in rheumatoid arthritis
- Ultrasound scoring systems: assessing disease activity in rheumatoid arthritis